17 Results

People

  1. Curran
    Curran
  2. O'Reilly
    O'Reilly
  3. Kernan
    Kernan
  4. Prockop
    Prockop
  5. Brentjens
    Brentjens
  6. Riviere
    Riviere
  7. Sadelain
    Sadelain
  8. Sauter
    Sauter
  9. Boulad
    Boulad
  10. Kobos
    Kobos

Groups

  1. Center for Hematologic Malignancies (17)
  2. Department of Medicine (17)
  3. GSK Faculty (17)
  4. Hematologic Malignancies Research (17)
  5. Immunology Program Faculty (17)
  6. Pediatrics, Department of (17)
  7. Sloan Kettering Institute Faculty (17)
  8. Stem Cell Transplantation and Cellular Therapy Service (17)
  9. Tow Center for Developmental Oncology (TCDO) (17)
  10. Hematologic Malignancies, Division of (16)
  1. "Hematologic Malignancies Research"
  2. "Kevin Curran"
  3. "Richard O'Reilly"
Formats
  1. Meeting Abstract (14)
  2. Journal Article (3)
Groups
  1. Center for Hematologic Malignancies (17)
  2. Department of Medicine (17)
  3. GSK Faculty (17)
  4. Hematologic Malignancies Research (17)
  5. Immunology Program Faculty (17)
  6. Pediatrics, Department of (17)

More Groups

People
  1. Kevin Curran (17)
  2. Richard O'Reilly (17)
  3. Nancy Kernan (16)
  4. Farid Boulad (12)
  5. Susan Prockop (12)
  6. Isabelle Riviere (11)

More People

Years
  1. 2023 (1)
  2. 2020 (4)
  3. 2019 (3)
  4. 2017 (1)
  5. 2016 (2)
  6. 2015 (2)

More Years

Publications
  1. Blood (8)
  2. Biology of Blood and Marrow Transplantation (3)
  3. Bone Marrow Transplantation (3)
  4. Cancer Research (1)
  5. Journal of Clinical Investigation (1)
  6. Pediatric Blood and Cancer (1)
Publishers
  1. American Society of Hematology (8)
  2. Elsevier Inc. (3)
  3. Nature Publishing Group (3)
  4. American Association for Cancer Research (1)
  5. American Society for Clinical Investigation (1)
  6. Wiley Periodicals, Inc (1)

Results (17)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Long term follow-up after treatment with allogeneic off-the-shelf CAR T cell therapy for relapsed or refractory B-cell malignancies
    Meeting Abstract

    Shahid, S.; Flynn, G. C.; Mauguen, A.; Bieler, J.; Prockop, S. E.; Scaradavou, A.; Boelens, J. J.; Sauter, C. S.; Perales, M. A.; Giralt, S. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Low toxicity and favorable overall survival in relapsed/refractory B-ALL following CAR T cells and CD34-selected T-cell depleted allogeneic hematopoietic cell transplant
    Journal Article

    Fabrizio, V. A.; Kernan, N. A.; Boulad, F.; Cancio, M.; Allen, J.; Higman, M.; Margossian, S. P.; Mauguen, A.; Prockop, S.; Scaradavou, A.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Durable remission following "off-the-shelf" chimeric antigen receptor (CAR) T-cells in patients with relapse/refractory (R/R) B-cell malignancies
    Meeting Abstract

    Curran, K. J.; Sauter, C. S.; Kernan, N. A.; Prockop, S. E.; Boulad, F.; Perales, M.; Giralt, S. A.; Riviere, I.; Wang, X.; Boelens, J. J.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Outcomes of two chemotherapy-based preparatory regimens compared to tbi-based conditioning when used with CD34(+) selected T-cell depleted alloHCT for high risk hematologic malignancies: Prospective clinical trial NCT 01119066
    Meeting Abstract

    O'Reilly, R. J.; Koehne, G.; Boulad, F.; Heller, G.; Klein, E.; Barker, J. N.; Castro-Malaspina, H.; Curran, K. J.; Hsu, K. C.; Jakubowski, A. A.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation
    Journal Article

    Prockop, S.; Doubrovina, E.; Suser, S.; Heller, G.; Barker, J.; Dahi, P.; Perales, M. A.; Papadopoulos, E.; Sauter, C.; Castro-Malaspina, H.; more...
    Journal of Clinical Investigation (2020)

    Fulltext@MSK | Save
  • Conditioning prior to CAR T cells predicts response and survival in pediatric/young adult relapse/refractory (R/R) B-ALL
    Meeting Abstract

    Curran, K. J.; Margossian, S.; Kernan, N. A.; Boulad, F.; Cancio, M.; Prockop, S. E.; Scaradavou, A.; Spitzer, B.; Szenes, V.; Riviere, I.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL
    Journal Article

    Curran, K. J.; Margossian, S. P.; Kernan, N. A.; Silverman, L. B.; Williams, D. A.; Shukla, N.; Kobos, R.; Forlenza, C. J.; Steinherz, P.; Prockop, S.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Conditioning prior to CD19-specific CAR (19-28Z) T cells predicts response and survival in pediatric relapse/refractory (R/R) B-ALL
    Meeting Abstract

    Curran, K.; Margossian, S.; Kernan, N.; Prockop, S.; Boulad, F.; Cancio, M.; Szenes, V.; Kung, A.; Boelens, J. J.; O'Reilly, R.; more...
    Bone Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • High dose cyclophosphamide and pre-treatment disease burden dictate response and survival in a multicenter clinical trial using CD19-specific CAR T cells for relapsed/refractory B-ALL
    Meeting Abstract

    Curran, K. J.; Margossian, S. P.; Kernan, N. A.; Silverman, L. B.; Park, J. H.; Sauter, C. S.; Smith, E. L.; Boulad, F.; Cancio, M. I.; Forlenza, C.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Germline mutations in cancer predisposition genes in a subset of pediatric oncology patients undergoing targeted solid tumor sequencing using matched normal DNA
    Meeting Abstract

    Walsh, M.; Shukla, N.; Joseph, V.; Kentsis, A.; Curran, K.; Kobos, R.; Arnold, A.; Harlan, M.; Kennedy, J.; Schrader, K.; more...
    Pediatric Blood and Cancer (2016)

    Fulltext@MSK | Save